AngioDynamics Inc
Suletud
SektorTervishoid
11.58 4.8
Ülevaade
Aktsiahinna muutus
24h
Min
10.68
Max
11.45
Sissetulek | 4.3M -7.1M |
|---|---|
Müük | -5.7M 81M |
Aktsiakasum | -0.04 |
Kasumimarginaal | -8.771 |
Töötajad | 632 |
EBITDA | 29M 377K |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +74.31% upside |
Järgmine tulemuste avaldamine | 5. jaan 2027 |
|---|
Turukapital | -174M 479M |
|---|---|
Eelmine avamishind | 6.78 |
Eelmine sulgemishind | 11.58 |
AngioDynamics Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
AngioDynamics Inc Prognoos
Hinnasiht
By TipRanks
74.31% tõus
12 kuu keskmine prognoos
Keskmine 19 USD 74.31%
Kõrge 20 USD
Madal 18 USD
Põhineb 2 Wall Streeti analüütiku instrumendi AngioDynamics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
